Form 4: Medpace Holdings Director Fred B. Davenport Jr. Executes Stock Option and Sells Shares
SEC Form 4 Filing
Director Fred B. Davenport Jr. of Medpace Holdings, Inc. exercised stock options and sold a portion of the acquired shares on April 24, 2025.
Summary
- On April 24, 2025, Fred B. Davenport Jr., a director of Medpace Holdings, Inc., exercised a stock option to acquire 4,710 shares of common stock at a price of $57.17 per share.
- Following the exercise of the option, Davenport sold 1,712 shares of common stock at a price of $301.82 per share.
- After these transactions, Davenport directly owns 2,998 shares of Medpace Holdings, Inc. common stock.
- Davenport also indirectly owns 2,000 shares through a trust.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transactions may have a minor impact on shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 05/16/2019 | Stock option vested in full |
| 04/24/2025 | Earliest transaction date: stock option exercise and share sale |
| 04/28/2025 | Date of signature for the Form 4 filing |
| 08/13/2025 | Expiration date of the stock option |
Keywords
Medpace Holdings, MEDP, Director, Stock Option, Share Sale, Form 4, Davenport
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.